glp 1 pet scan GLP-1 Drug Use May Create New Challenges in Cancer Imaging GLP-1 agonists pose emerging challenge

From metabolism to mind: The expanding role of the GLP-1 receptor in neurotherapeutics

While these drugs are widely praised for helping people lose significant weight, the study found that physical activity did not increase alongside that weight lossas many might expect

Abstract Sodium-glucose cotransporters inhibitors (SGLT2-i) and GLP-1 receptor agonists (GLP1-RA) are glucose-lowering drugs that are proved to reduce the cardiovascular (CV) risk in type 2 diabetes mellitus (T2DM)

Ovarian cancer is the deadliest gynecological malignancy

If any of these side effects last or get worse, let us know so we can help

Hi Christa, I recorded the video right away, but it took FOREVER to get it to upload to Vimeo